A single-cycle recombinant VSV vaccine displaying the Hendra virus glycoprotein uniformly protects against Hendra and Nipah virus challenge. [PDF]
Pigeaud DD +10 more
europepmc +1 more source
Antigenic and structural insights into Langya henipavirus attachment glycoprotein. [PDF]
Li Y +9 more
europepmc +1 more source
A highly potent, stable, and safe dePEGylated lipopeptide against Nipah virus and related henipaviruses. [PDF]
Wang Y +15 more
europepmc +1 more source
Bifurcations and optimal control in Nipah virus epidemiology. [PDF]
Haque Z +4 more
europepmc +1 more source
Nipah virus on the radar: The choice to catch early or catch up later. [PDF]
Lacey H, Jain S, Reinis A, Jain N.
europepmc +1 more source
A recombinant Cedar virus preclinical model that recapitulates neurological features of henipavirus disease. [PDF]
Huaman C +11 more
europepmc +1 more source
Validation of Chemical Inactivation Protocols for Henipavirus-Infected Tissue Samples. [PDF]
Silva-Ayala D, Griffiths A.
europepmc +1 more source
Nipah Virus Antibodies in Bats, the Philippines, 2013-2022. [PDF]
Kaku Y +22 more
europepmc +1 more source
Nipah virus infection: preparedness for the pathological diagnosis of an emerging Paramyxoviridae disease with epidemic potential. [PDF]
Borges CDSC +13 more
europepmc +1 more source
Infectome analysis of bat kidneys from Yunnan province, China, reveals novel henipaviruses related to Hendra and Nipah viruses and prevalent bacterial and eukaryotic microbes. [PDF]
Kuang G +15 more
europepmc +1 more source

